Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Orestes E. Solis

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology

English

“Fantastic Thinking” in Pathologically Proven Pick Disease

Cognitive and Behavioral Neurology

Mental Health

Neuropsychology

Cognitive Neuroscience

Physiological Psychology

Psychiatry

Medicine

2010

English

Related publications

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology

English

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Journal of Neuro-Oncology

English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia

English

RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

International Journal of Radiation Oncology Biology Physics

English

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi

Oncology

2019

English

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

English

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

New England Journal of Medicine

Medicine

2017

English

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Oncotarget

Oncology

2017

English

Neural Progenitor Cell (NPC) Sparing Radiation Therapy (RT) Plus Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Multiforme (GBM) Associated With Neurocognitive Function but Not Tumor Outcomes: Results of a Prospective Clinical Trial

International Journal of Radiation Oncology Biology Physics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Orestes E. Solis

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

“Fantastic Thinking” in Pathologically Proven Pick Disease

Related publications

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Neural Progenitor Cell (NPC) Sparing Radiation Therapy (RT) Plus Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Multiforme (GBM) Associated With Neurocognitive Function but Not Tumor Outcomes: Results of a Prospective Clinical Trial